SCFβ‐TrCP ubiquitinates CHK1 in an AMPK‐dependent manner in response to glucose deprivation
The ATR/CHK1 pathway is a key effector of cellular response to DNA damage and therefore is a critical regulator of genomic stability. While the ATR/CHK1 pathway is often inactivated by mutations, CHK1 itself is rarely mutated in human cancers. Thus, cellular levels of CHK1 likely play a key role in...
Main Authors: | Ying Ma, Danrui Cui, Xiufang Xiong, Hiroyuki Inuzuka, Wenyi Wei, Yi Sun, Brian J. North, Yongchao Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-02-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.12403 |
Similar Items
-
Datasets from an interaction proteomics screen for substrates of the SCFβTrCP ubiquitin ligase
by: Roberto Magliozzi, et al.
Published: (2015-09-01) -
β-TrCP-mediated ubiquitination and degradation of Dlg5 regulates hepatocellular carcinoma cell proliferation
by: Dongping Wang, et al.
Published: (2019-11-01) -
NORE1A Regulates MDM2 Via β-TrCP
by: M. Lee Schmidt, et al.
Published: (2016-03-01) -
SCFβ-TRCP E3 ubiquitin ligase targets the tumor suppressor ZNRF3 for ubiquitination and degradation
by: Yanpeng Ci, et al.
Published: (2018-03-01) -
An inhibitor of interaction between the transcription factor NRF2 and the E3 ubiquitin ligase adapter β-TrCP delivers anti-inflammatory responses in mouse liver
by: Cuadrado, A., et al.
Published: (2022)